Difference between revisions of "Part:BBa K3244015"
Soumo sarkar (Talk | contribs) (→MIT MAHE 2020) |
|||
| Line 18: | Line 18: | ||
<!-- --> | <!-- --> | ||
| − | == | + | ==MIT_MAHE 2020== |
'''Summary''' | '''Summary''' | ||
| − | Interleukin-18 (IL-18) is a member of IL-1 family of cytokines. It is synthesized as an inactive precursor which can be processed by caspase-1 to an active cytokine. The precursor is constitutively present in nearly all cells in healthy humans and animals. Its activity is balanced by the presence of a high affinity naturally occurring IL-18 binding protein. It plays a major role in production of interferon -γ from T-cells and natural killer cells. It is said to play a part in several autoimmune diseases, myocardial function, emphysema, metabolic syndromes, psoriasis, inflammatory bowel disease, hemophagocytic syndromes, macrophage activation syndrome, sepsis, and acute kidney injury. In humans, disease severity can be associated with an imbalance of IL-18 to IL-18BP such that the levels of free IL-18 are elevated in the circulation. | + | Interleukin-18 (IL-18) is a member of IL-1 family of cytokines. It is synthesized as an inactive precursor which can be processed by caspase-1 to an active cytokine. The precursor is constitutively present in nearly all cells in healthy humans and animals. Its activity is balanced by the presence of a high affinity naturally occurring IL-18 binding protein. It plays a major role in production of interferon -γ from T-cells and natural killer cells. It is said to play a part in several autoimmune diseases, myocardial function, emphysema, metabolic syndromes, psoriasis, inflammatory bowel disease, hemophagocytic syndromes, macrophage activation syndrome, sepsis, and acute kidney injury. In humans, disease severity can be associated with an imbalance of IL-18 to IL-18BP such that the levels of free IL-18 are elevated in the circulation. |
==References== | ==References== | ||
1. Dinarello, C. A., Novick, D., Kim, S., & Kaplanski, G. (2013). Interleukin-18 and IL-18 binding protein. Frontiers in immunology, 4, 289. https://doi.org/10.3389/fimmu.2013.00289 | 1. Dinarello, C. A., Novick, D., Kim, S., & Kaplanski, G. (2013). Interleukin-18 and IL-18 binding protein. Frontiers in immunology, 4, 289. https://doi.org/10.3389/fimmu.2013.00289 | ||
Latest revision as of 17:59, 23 October 2020
IL-18
IL-18 cytokine for TRUCK CAR
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
MIT_MAHE 2020
Summary
Interleukin-18 (IL-18) is a member of IL-1 family of cytokines. It is synthesized as an inactive precursor which can be processed by caspase-1 to an active cytokine. The precursor is constitutively present in nearly all cells in healthy humans and animals. Its activity is balanced by the presence of a high affinity naturally occurring IL-18 binding protein. It plays a major role in production of interferon -γ from T-cells and natural killer cells. It is said to play a part in several autoimmune diseases, myocardial function, emphysema, metabolic syndromes, psoriasis, inflammatory bowel disease, hemophagocytic syndromes, macrophage activation syndrome, sepsis, and acute kidney injury. In humans, disease severity can be associated with an imbalance of IL-18 to IL-18BP such that the levels of free IL-18 are elevated in the circulation.
References
1. Dinarello, C. A., Novick, D., Kim, S., & Kaplanski, G. (2013). Interleukin-18 and IL-18 binding protein. Frontiers in immunology, 4, 289. https://doi.org/10.3389/fimmu.2013.00289